LIPPOLDT DARIN (Chief Legal Officer) sold 15.4% of their position (10K shares) of NEUROCRINE BIOSCIENCES INC on the open market
Open‑market sale worth $1.80M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/13/2026ACC: 0001504783-26-000017
Officer· Chief Legal Officer
Since Feb 2019
-10K
Net shares
Net seller
$1.80M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$81.49
Trade value
$814.90K
% of position
18.3%
7/9/2026
54.73K→64.73K
Common Stock
Direct
Shares
−10K
Price / share
$179.60
Trade value
$1.80M
% of position
15.4%
7/9/2026
64.73K→54.73K
Total
Net shares
+0.00
Net value
-$981.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/9/2026 | M · Option Exercise | +10K | $81.49 | $814.90K | 18.3% | 54.73K | 64.73K |
| Common Stock Direct | 7/9/2026 | S · Sale | −10K | $179.60 | $1.80M | 15.4% | 64.73K | 54.73K |
| Total | +0.00 | -$981.11K | ||||||
Derivative Transactions1
Non-Qualified Stock Option
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
81.49
Held after
4.96K
Exercisable
—
7/9/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option Direct | Common Stock10K shares | 7/9/2026 | M · Option Exercise | −10K | 81.49 | — | 4.96K |